Publicaciones en las que colabora con Fernando Alfonso Manterola (27)

2024

  1. Invasive Treatment Strategy in Adults With Frailty and Non-ST-Segment Elevation Myocardial Infarction: A Secondary Analysis of a Randomized Clinical Trial

    JAMA network open, Vol. 7, Núm. 3, pp. e240809

2023

  1. Changes in the Treatment Strategy Following Intracoronary Pressure Wire in a Contemporaneous Real-Life Cohort of Patients With Intermediate Coronary Stenosis. Results From a Nationwide Registry

    Cardiovascular Revascularization Medicine, Vol. 51, pp. 55-64

  2. Complete or Culprit-Only PCI in Older Patients with MI

    New England Journal of Medicine

  3. Complete or Culprit-Only PCI in Older Patients with MI

    The New England journal of medicine

2022

  1. Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial

    European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588

2021

  1. Baseline CHA2DS2-VASc score and prognosis in octogenarians with non-ST segment elevation acute coronary syndrome

    International Journal of Clinical Practice, Vol. 75, Núm. 6

  2. REC: Interventional Cardiology en el año de la COVID-19

    REC: Interventional Cardiology, Vol. 3, Núm. 4, pp. 239-244

2020

  1. Primeros dos años de REC: Interventional Cardiology

    REC: Interventional Cardiology, Vol. 2, Núm. 4, pp. 233-238

2019

  1. Baseline Risk Stratification of Patients Older Than 75 Years With Infarction and Cardiogenic Shock Undergoing Primary Angioplasty

    Revista Espanola de Cardiologia, Vol. 72, Núm. 12, pp. 1005-1011

  2. Invasive Versus Conservative Strategy in Frail Patients With NSTEMI: The MOSCA-FRAIL Clinical Trial Study Design

    Revista Espanola de Cardiologia, Vol. 72, Núm. 2, pp. 154-159

  3. Mitral Regurgitation and Prognosis After Non-ST-Segment Elevation Myocardial Infarction in Very Old Patients

    Journal of the American Geriatrics Society, Vol. 67, Núm. 8, pp. 1641-1648

  4. REC: Interventional Cardiology: Una nueva revista, pero no una revista más

    REC: Interventional Cardiology, Vol. 1, Núm. 1, pp. 2-3

2018

  1. 3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents

    JACC: Cardiovascular Interventions, Vol. 11, Núm. 10, pp. 981-991

  2. Multivessel disease in patients over 75 years old with ST elevated myocardial infarction. Current management strategies and related clinical outcomes in the ESTROFA MI + 75 nation-wide registry

    Cardiovascular Revascularization Medicine, Vol. 19, Núm. 5, pp. 580-588

2017

  1. Angioplastia primaria en mayores de 75 años. Perfil de pacientes y procedimientos, resultados y predictores pronósticos en el registro ESTROFA IM + 75

    Revista Espanola de Cardiologia, Vol. 70, Núm. 2, pp. 81-87

  2. Usefulness of Drug-Eluting Balloons for Bare-Metal and Drug-Eluting In-Stent Restenosis (from the RIBS IV and V Randomized Trials)

    American Journal of Cardiology, Vol. 119, Núm. 7, pp. 983-990

2016

  1. Everolimus-eluting stents in patients with bare-metal and drug-eluting in-stent restenosis

    Circulation: Cardiovascular Interventions, Vol. 9, Núm. 7

  2. Long-Term Results of Everolimus-Eluting Stents Versus Drug-Eluting Balloons in Patients With Bare-Metal In-Stent Restenosis: 3-Year Follow-Up of the RIBS V Clinical Trial

    JACC: Cardiovascular Interventions, Vol. 9, Núm. 12, pp. 1246-1255

2015

  1. Dual Antiplatelet Therapy for 6 Months vs 12 Months After New-generation Drug-eluting Stent Implantation: Matched Analysis of ESTROFA-DAPT and ESTROFA-2

    Revista Espanola de Cardiologia, Vol. 68, Núm. 10, pp. 838-845

  2. Editorial and scientific excellence of biomedical journals: Is the impact factor everything?

    Archivos de Cardiologia de Mexico, Vol. 85, Núm. 4, pp. 265-269